This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Must-Own Dividend Stocks for 2013


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Drug giant Pfizer (PFE - Get Report) is another must-own dividend name for 2013. The $200 billion pharmaceutical firm owns some of the most well known prescription pills on the market today -- and despite the threat of patent drop-offs that's been haranguing the whole pharma industry, Pfizer has been showing off its ability to save its bottom line with cost savings and M&A. Right now, this stock pays out a 3.42% dividend yield.

In 2009, Pfizer bought drugmaker Wyeth in a deal that dramatically increased the combined firm's drug pipeline while realizing massive merger cost savings. As a result, while Wall Street remains fixated on the negative effects from Lipitor's patent loss, Pfizer is pushing along a slew of phase I, II and III drug candidates that have the potential to reach blockbuster status.

Financially, Pfizer is in stellar shape. The firm boasts a $10 billion net cash position post-merger, on top of PFE's already strong cash flow generation abilities. Those factors should help keep the hefty payout from this big pharma firm intact for the foreseeable future. Once investors realize that, there should be some capital gains to go along with it.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
GRMN $40.60 -1.10%
INTC $29.80 -0.35%
PPL $38.09 -0.60%
PFE $33.24 -1.00%
T $38.83 0.23%


Chart of I:DJI
DOW 17,641.30 -19.41 -0.11%
S&P 500 2,043.09 -7.54 -0.37%
NASDAQ 4,689.4880 -27.6060 -0.59%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs